Does VINCRISTINE Cause Second primary malignancy? 908 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 908 reports of Second primary malignancy have been filed in association with VINCRISTINE (VinCRIStine Sulfate). This represents 1.3% of all adverse event reports for VINCRISTINE.
908
Reports of Second primary malignancy with VINCRISTINE
1.3%
of all VINCRISTINE reports
420
Deaths
158
Hospitalizations
How Dangerous Is Second primary malignancy From VINCRISTINE?
Of the 908 reports, 420 (46.3%) resulted in death, 158 (17.4%) required hospitalization, and 83 (9.1%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VINCRISTINE. However, 908 reports have been filed with the FAERS database.
What Other Side Effects Does VINCRISTINE Cause?
Febrile neutropenia (8,676)
Off label use (6,562)
Disease progression (5,252)
Neutropenia (4,982)
Drug ineffective (4,084)
Pyrexia (3,460)
Product use in unapproved indication (3,073)
Thrombocytopenia (2,940)
Sepsis (2,791)
Anaemia (2,603)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
METHOTREXATE (414)
Which VINCRISTINE Alternatives Have Lower Second primary malignancy Risk?
VINCRISTINE vs VINDESINE
VINCRISTINE vs VINORELBINE
VINCRISTINE vs VINORELBINE\VINORELBINE
VINCRISTINE vs VIREAD
VINCRISTINE vs VISIPAQUE